Probiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis: A Meta-analysis

@article{Mardini2014ProbioticMV,
  title={Probiotic Mix VSL\#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis: A Meta-analysis},
  author={H. Mardini and A. Grigorian},
  journal={Inflammatory Bowel Diseases},
  year={2014},
  volume={20},
  pages={1562–1567}
}
Background:VSL#3 is a probiotic mix preparation reported to be effective in the treatment of mild to moderately active ulcerative colitis. We aimed to perform a systematic review of the literature and a meta-analysis of studies on its efficacy. Methods:The searched databases included PubMed, Scopus, and ScienceDirect. The Mantel–Haenszel method was used to pool the effect- ize across studies, and the odds ratios (ORs) and 95% confidence intervals (CIs) of experiencing a specific outcome were… Expand
Probiotics as a Coadjuvant Factor in Active or Quiescent Inflammatory Bowel Disease of Adults—A Meta-Analytical Study
TLDR
There are data showing an additional beneficial effect of probiotics on active ulcerative colitis and more and better studies are needed which assess its possible therapeutic efficacy for quiescent ulceration and for Crohn’s disease. Expand
Comparison of maintenance effect of probiotics and aminosalicylates on ulcerative colitis: A meta-analysis of randomized controlled trials
TLDR
Probiotics and aminosalicylates both showed a maintenance effect on ulcerative colitis, however, more well-designed RCTs are required. Expand
Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis
TLDR
FMT is potentially useful in UC disease management but better-designed RCTs are still required to confirm the findings before wide adoption is suggested and basic guidelines are needed imminently to identify the right patient population and to standardize the process of FMT. Expand
Probiotics and the Microbiome in Celiac Disease: A Randomised Controlled Trial
TLDR
The probiotic formula when taken orally over the 12-week period did not significantly alter the microbiota measured in this population of people with celiac disease, and no statistically significant changes between the groups in the faecal microbiota counts or blood safety measures were revealed. Expand
The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis
TLDR
It is concluded that a validated scale is necessary to determine the state of patients with UC and probiotics containing bifidobacteria are promising for the treatment of active UC. Expand
Probiotic Medilac-S® for the induction of clinical remission in a Chinese population with ulcerative colitis: A systematic review and meta-analysis
TLDR
Evidence suggests Medilac-S® adjunctive therapy should be considered standard care for UC in a Chinese population because it aids in the induction of clinical remission, improves symptoms of the gastrointestinal tract and reduces risk of AEs. Expand
Estudi de diferents moduladors de la microbiota i el seu efecte sobre la colitis ulcerosa i la diversitat microbiana
TLDR
It is concluded that a validated scale is necessary to determine the state of patients with UC and probiotics containing bifidobacteria are promising for the treatment of active UC. Expand
Probiotic Bacterial and Fungal Strains: Claims with Evidence
TLDR
The evidence on bacterial and yeast probiotics has considerably expanded during recent years, and accumulated data allow one to make informed decisions about the effectiveness of probiotics and about how to reduce the use of those without proven efficacy. Expand
Review of the role of probiotics in gastrointestinal diseases in adults.
TLDR
Certain probiotics, different for each process, have proven to be effective and beneficial in cases of acute infectious diarrhoea, antibiotic-associated diarrhoeA, Clostridium difficile-associated diarrhea, pouchitis and Helicobacter pylori infection eradication. Expand
Review of the role of probiotics in gastrointestinal diseases in adults
TLDR
Certain probiotics, different for each process, have proven to be effective and beneficial in cases of acute infectious diarrhoea, antibiotic-associated diarrhoeA, Clostridium difficile-associated diarrhea, pouchitis and Helicobacter pylori infection eradication. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 16 REFERENCES
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis
TLDR
Treatment of patients with mild to moderate UC, not responding to conventional therapy, with VSL#3 resulted in a combined induction of remission/response rate of 77% with no adverse events. Expand
Effect of a Probiotic Preparation (VSL#3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis
TLDR
This is the first pediatric, randomized, placebo-controlled, double-blind trial that suggests the efficacy and safety of a highly concentrated mixture of probiotic bacterial strains (VSL#3) in active UC and demonstrates its role in maintenance of remission. Expand
The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis.
  • A. Sood, V. Midha, +4 authors R. Tandon
  • Medicine
  • Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
  • 2009
TLDR
VSL#3 is safe and effective in achieving clinical responses and remissions in patients with mild-to-moderately active UC and had significantly greater decreases in UCDAI scores and individual symptoms at weeks 6 and 12, compared with the placebo group. Expand
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study
TLDR
VSL#3 supplementation is safe and able to reduce UCDAI scores in patients affected by relapsing mild-to-moderate UC who are under treatment with 5-ASA and/or immunosuppressants at stable doses. Expand
Effect of Probiotics on Inducing Remission and Maintaining Therapy in Ulcerative Colitis, Crohn's Disease, and Pouchitis: Meta-analysis of Randomized Controlled Trials
TLDR
Administration of probiotics results in additional benefit in inducing remission of patients with UC and can provide the similar effect as 5-aminosalicylic acid on maintaining remission of UC, although no additional adverse events presented. Expand
Probiotics for induction of remission in ulcerative colitis.
TLDR
There is limited evidence that probiotics added to standard therapy may provide modest benefits in terms of reduction of disease activity in patients with mild to moderately severe ulcerative colitis, and larger randomised controlled trials are needed to determine whether probiotics can be used as an alternative to current treatment modalities. Expand
Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.
TLDR
Balsalazide/VSL#3 may be a very good choice in the treatment of active mild-to-moderate active ulcerative colitis instead of balsalAZide alone or mesalazine. Expand
Probiotics in the Treatment of Human Inflammatory Bowel Diseases: Update 2011
TLDR
The clinical studies regarding probiotics before October 2007 are outlined, providing new insights into the role of probiotics for inducing and maintaining remission of IBD, and some of the breakthroughs are highlighted, especially regarding induction of remission for ulcerative colitis. Expand
Probiotics in the treatment of inflammatory bowel disease.
TLDR
Not all probiotic bacteria have similar therapeutic effects, soorously designed, controlled clinical trials, to investigate the unresolved issues related to efficacy, dose, duration of use, single or multistrain formulation, and the concomitant use of prebiotics, synbiotics or antibiotics, are vital. Expand
Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies.
TLDR
The rationale for modulating the microbiota for treatment of IBD and IBS is assessed, and whether current concepts are simplistic and overstated or simply under-researched is discussed. Expand
...
1
2
...